Situation of Mycobacterium tuberculosis drug resistances in Spain;Situación de las resistencias a fármacos de Mycobacterium tuberculosis en España

Revista Espanola de Quimioterapia

Volumn 21, Issue 1, 2008, Pages 22-25

  Jimenez M S ^a   Casal Román, Manuel ^b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Centro de Referencia de Micobacterias   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Antituberculous agents; Resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHEMOPROPHYLAXIS; FEMALE; HUMAN; IMMIGRANT; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROBABILITY; SPAIN; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SPAIN;

EID: 46049085189     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. WHO. The Global plan to Stop TB 2006-2015. Document WHO/HTM/STB/2006.35
2. WHO. Extensively drug resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006,81:430-82.